AAAAAA
Results:
1-20
|
Results: 20
Authors:
OCONNELL MJ
LAURIE JA
KAHN M
FITZGIBBONS RJ
ERLICHMAN C
SHEPHERD L
MOERTEL CG
KOCHA WI
PAZDUR R
WIEAND HS
RUBIN J
VUKOV AM
DONOHUE JH
KROOK JE
FIGUEREDO A
Citation: Mj. Oconnell et al., PROSPECTIVELY RANDOMIZED TRIAL OF POSTOPERATIVE ADJUVANT CHEMOTHERAPYIN PATIENTS WITH HIGH-RISK COLON-CANCER, Journal of clinical oncology, 16(1), 1998, pp. 295-300
Authors:
REID JM
KOVACH JS
OCONNELL MJ
BAGNIEWSKI PG
MOERTEL CG
Citation: Jm. Reid et al., CLINICAL AND PHARMACOKINETIC STUDIES OF HIGH-DOSE LEVAMISOLE IN COMBINATION WITH 5-FLUOROURACIL IN PATIENTS WITH ADVANCED CANCER, Cancer chemotherapy and pharmacology, 41(6), 1998, pp. 477-484
Authors:
GOLDBERG RM
FLEMING TR
TANGEN CM
MOERTEL CG
MACDONALD JS
HALLER DG
LAURIE JA
Citation: Rm. Goldberg et al., SURGERY FOR RECURRENT COLON-CANCER - STRATEGIES FOR IDENTIFYING RESECTABLE RECURRENCE AND SUCCESS RATES AFTER RESECTION, Annals of internal medicine, 129(1), 1998, pp. 27
Authors:
GOLDBERG RM
HATFIELD AK
KAHN M
SARGENT DJ
KNOST JA
OCONNELL MJ
KROOK JE
MAILLIARD JA
WIESENFELD M
SCHAEFER PL
TIRONA MT
MOERTEL CG
Citation: Rm. Goldberg et al., PROSPECTIVELY RANDOMIZED NORTH CENTRAL CANCER-TREATMENT GROUP TRIAL OF INTENSIVE-COURSE FLUOROURACIL COMBINED WITH THE L-ISOMER OF INTRAVENOUS LEUCOVORIN, ORAL LEUCOVORIN, OR INTRAVENOUS LEUCOVORIN FOR THE TREATMENT OF ADVANCED COLORECTAL-CANCER, Journal of clinical oncology, 15(11), 1997, pp. 3320-3329
Authors:
HARTMANN LC
TSCHETTIER LK
HABERMANN TM
EBBERT LP
JOHNSON PS
MAILLIARD JA
LEVITT R
SUMAN VJ
WITZIG TE
WIEAND HS
MILLER LL
MOERTEL CG
Citation: Lc. Hartmann et al., GRANULOCYTE-COLONY-STIMULATING FACTOR IN SEVERE CHEMOTHERAPY-INDUCED AFEBRILE NEUTROPENIA, The New England journal of medicine, 336(25), 1997, pp. 1776-1780
Authors:
TRENDLE MC
MOERTEL CG
KVOLS LK
Citation: Mc. Trendle et al., INCIDENCE AND MORBIDITY OF CHOLELITHIASIS IN PATIENTS RECEIVING CHRONIC OCTREOTIDE FOR METASTATIC CARCINOID AND MALIGNANT ISLET-CELL TUMORS, Cancer, 79(4), 1997, pp. 830-834
Authors:
MARTENSON JA
HYLAND G
MOERTEL CG
MAILLIARD JA
OFALLON JR
COLLINS RT
MORTON RF
TEWFIK HH
MOORE RL
FRANK AR
URIAS RE
DEMING RL
Citation: Ja. Martenson et al., OLSALAZINE IS CONTRAINDICATED DURING PELVIC RADIATION-THERAPY - RESULTS OF A DOUBLE-BLIND, RANDOMIZED CLINICAL-TRIAL, International journal of radiation oncology, biology, physics, 35(2), 1996, pp. 299-303
Authors:
DONOHUE JH
WILLIAMS S
CHA S
WINDSCHITL HE
WITZIG TE
NELSON H
FITZGIBBONS RJ
WIEAND HS
MOERTEL CG
Citation: Jh. Donohue et al., PERIOPERATIVE BLOOD-TRANSFUSIONS DO NOT AFFECT DISEASE RECURRENCE OF PATIENTS UNDERGOING CURATIVE RESECTION OF COLORECTAL-CARCINOMA - A MAYO NORTH CENTRAL CANCER-TREATMENT GROUP-STUDY/, Journal of clinical oncology, 13(7), 1995, pp. 1671-1678
Authors:
MOERTEL CG
FLEMING TR
MACDONALD JS
HALLER DG
LAURIE JA
TANGEN CM
UNGERLEIDER JS
EMERSON WA
TORMEY DC
GLICK JH
VEEDER MH
MAILLIARD JA
Citation: Cg. Moertel et al., INTERGROUP STUDY OF FLUOROURACIL PLUS LEVAMISOLE AS ADJUVANT THERAPY FOR STAGE-II DUKES B2 COLON-CANCER, Journal of clinical oncology, 13(12), 1995, pp. 2936-2943
Authors:
GOLDBERG RM
MOERTEL CG
WIEAND HS
KROOK JE
SCHUTT AJ
VEEDER MH
MAILLIARD JA
DALTON RJ
Citation: Rm. Goldberg et al., A PHASE-III EVALUATION OF A SOMATOSTATIN ANALOG (OCTREOTIDE) IN THE TREATMENT OF PATIENTS WITH ASYMPTOMATIC ADVANCED COLON-CARCINOMA, Cancer, 76(6), 1995, pp. 961-966
Authors:
MOERTEL CG
FLEMING TR
MACDONALD JS
HALLER DG
LAURIE JA
TANGEN CM
UNGERLEIDER JS
EMERSON WA
TORMEY DC
GLICK JH
VEEDER MH
MAILLIARD JA
GRAFF J
Citation: Cg. Moertel et al., FLUOROURACIL PLUS LEVAMISOLE AS EFFECTIVE ADJUVANT THERAPY AFTER RESECTION OF STAGE-III COLON-CARCINOMA - A FINAL REPORT, Annals of internal medicine, 122(5), 1995, pp. 321-326
Authors:
LOPRINZI CL
LAURIE JA
WIEAND HS
KROOK JE
NOVOTNY PJ
KUGLER JW
BARTEL J
LAW M
BATEMAN M
KLATT NE
DOSE AM
ETZELL PS
NELIMARK RA
MAILLIARD JA
MOERTEL CG
Citation: Cl. Loprinzi et al., PROSPECTIVE EVALUATION OF PROGNOSTIC VARIABLES FROM PATIENT-COMPLETEDQUESTIONNAIRES, Journal of clinical oncology, 12(3), 1994, pp. 601-607
Authors:
CULLINAN SA
MOERTEL CG
WIEAND HS
OCONNELL MJ
POON MA
KROOK JE
MAILLIARD JA
TSCHETTER LK
Citation: Sa. Cullinan et al., CONTROLLED EVALUATION OF 3 DRUG-COMBINATION REGIMENS VERSUS FLUOROURACIL ALONE FOR THE THERAPY OF ADVANCED GASTRIC-CANCER, Journal of clinical oncology, 12(2), 1994, pp. 412-416
Authors:
MOERTEL CG
GUNDERSON LL
MAILLIARD JA
MCKENNA PJ
MARTENSON JA
BURCH PA
CHA SS
Citation: Cg. Moertel et al., EARLY EVALUATION OF COMBINED FLUOROURACIL AND LEUCOVORIN AS A RADIATION ENHANCER FOR LOCALLY UNRESECTABLE, RESIDUAL, OR RECURRENT GASTROINTESTINAL CARCINOMA, Journal of clinical oncology, 12(1), 1994, pp. 21-27
Authors:
MOERTEL CG
Citation: Cg. Moertel, CEA FOR MONITORING COLON-CANCER - REPLY, JAMA, the journal of the American Medical Association, 271(5), 1994, pp. 346-347
Authors:
MOERTEL CG
Citation: Cg. Moertel, DRUG-THERAPY - CHEMOTHERAPY FOR COLORECTAL-CANCER, The New England journal of medicine, 330(16), 1994, pp. 1136-1142
Authors:
MOERTEL CG
JOHNSON CM
MCKUSICK MA
MARTIN JK
NAGORNEY DM
KVOLS LK
RUBIN J
KUNSELMAN S
Citation: Cg. Moertel et al., THE MANAGEMENT OF PATIENTS WITH ADVANCED CARCINOID-TUMORS AND ISLET-CELL CARCINOMAS, Annals of internal medicine, 120(4), 1994, pp. 302-309
Authors:
MOERTEL CG
FLEMING TR
MACDONALD JS
HALLER DG
LAURIE JA
Citation: Cg. Moertel et al., HEPATIC TOXICITY ASSOCIATED WITH FLUOROURACIL PLUS LEVAMISOLE ADJUVANT THERAPY, Journal of clinical oncology, 11(12), 1993, pp. 2386-2390
Authors:
MOERTEL CG
FLEMING TR
MACDONALD JS
HALLER DG
LAURIE JA
TANGEN C
Citation: Cg. Moertel et al., AN EVALUATION OF THE CARCINOEMBRYONIC ANTIGEN (CEA) TEST FOR MONITORING PATIENTS WITH RESECTED COLON-CANCER, JAMA, the journal of the American Medical Association, 270(8), 1993, pp. 943-947
Authors:
AHLQUIST DA
MOERTEL CG
MCGILL DB
Citation: Da. Ahlquist et al., SCREENING FOR COLORECTAL-CANCER, The New England journal of medicine, 329(18), 1993, pp. 1351-1351
Risultati:
1-20
|